KAS
AXSM icon

Kestra Advisory Services’s Axsome Therapeutics AXSM Stock Holding History

Kestra Advisory Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,053
Closed -$454K – 2662
2024
Q3 		$454K Sell
5,053
-75
-1% -$6.55K ﹤0.01% 1822
2024
Q2 		$413K Sell
5,128
-2,657
-34% -$197K ﹤0.01% 1903
2024
Q1 		$621K Buy
7,785
+1,691
+28% +$142K ﹤0.01% 1522
2023
Q4 		$485K Sell
6,094
-1,802
-23% -$120K ﹤0.01% 1550
2023
Q3 		$552K Sell
7,896
-1,592
-17% -$119K 0.01% 1318
2023
Q2 		$682K Sell
9,488
-314
-3% -$23.2K 0.01% 1167
2023
Q1 		$605K Buy
9,802
+1,719
+21% +$113K 0.01% 1184
2022
Q4 		$623K Sell
8,083
-2,134
-21% -$128K 0.01% 1270
2022
Q3 		$456K Sell
10,217
-3,952
-28% -$197K ﹤0.01% 1373
2022
Q2 		$543K Buy
14,169
+4,574
+48% +$145K 0.01% 1289
2022
Q1 		$397K Buy
9,595
+3,341
+53% +$104K ﹤0.01% 1416
2021
Q4 		$236K Sell
6,254
-130
-2% -$4.78K ﹤0.01% 1772
2021
Q3 		$210K Buy
6,384
+784
+14% +$30.6K ﹤0.01% 1947
2021
Q2 		$378K Buy
5,600
+1,627
+41% +$97.6K ﹤0.01% 1428
2021
Q1 		$225K Buy
+3,973
New +$279K ﹤0.01% 1656

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kestra Advisory Services's AXSM Position: Q4 2024 in Review

Kestra Advisory Services sold out of Axsome Therapeutics (AXSM) in Q4 2024, closing a stake of 5,053 shares — an estimated $454K sold.

Kestra Advisory Services first reported a position in AXSM in Q1 2021 and held it in 15 quarters. The position peaked at $682K in Q2 2023. 292 funds tracked by Wall St. Rank hold AXSM as of Q4 2024.

  • Kestra Advisory Services reported no remaining Axsome Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 5,053 Axsome Therapeutics shares in Q4 2024, an estimated $454K.
  • Kestra Advisory Services first reported a position in Axsome Therapeutics in Q1 2021 and held it in 15 quarters.
  • Kestra Advisory Services's Axsome Therapeutics position peaked at $682K in Q2 2023.
  • 292 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2024.

Based on Kestra Advisory Services's 13F filing for Q4 2024, filed 10 Feb 2025.